Suppr超能文献

负载LL37微球的活性炭-壳聚糖水凝胶敷料用于感染伤口的治疗:体内抗菌和抗毒素评估

Activated carbon-chitosan hydrogel dressing loaded with LL37 microspheres for the treatment of infected wounds: In vivo antimicrobial and antitoxin assessment.

作者信息

Lim Bee-Yee, Azmi Fazren, Ng Shiow-Fern

机构信息

National Pharmaceutical Regulatory Agency, 36, Jalan Profesor Diraja Ungku Aziz, PJS 13, 46200, Petaling Jaya, Selangor, Malaysia.

Centre for Drug Delivery Technology and Vaccine, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 50300, Kuala Lumpur, Malaysia.

出版信息

Drug Deliv Transl Res. 2025 Mar 22. doi: 10.1007/s13346-025-01835-7.

Abstract

Wound healing is a complex process which is crucial for recovery. Delayed wound healing which is caused by the presence of pathogens has posed significant clinical implications affecting millions of patients globally. Wounds infection caused by Pseudomonas aeruginosa present significant challenges due to their resistance to multiple antimicrobial drugs. The Gram-negative bacteria secretes endotoxin lipopolysaccharide (LPS), which impede wound healing and may lead to severe complications, including life-threatening sepsis. Previously, our laboratory has successfully developed a new hydrogel containing a synthetic antimicrobial peptide as an alternative therapy to conventional antibiotics. This hydrogel contains LL37 microspheres embedded into activated carbon-chitosan hydrogel (LL37-AC-CS). LL37-AC-CS has shown desirable physicochemical properties as well as promising antimicrobial and antitoxin activities in vitro. This current study has two main objectives. The first is to evaluate the in vivo antimicrobial efficacy of LL37-AC-CS hydrogel in full-thickness rat wounds infected with P. aeruginosa. The second objective is to investigate the antitoxin efficacy on the rat wound models treated with E. coli endotoxins LPS. The wound healing efficacy was assessed in terms of the macroscopic appearance, wound contraction rate, histology, and wound tissue biochemical markers. As a result, the LL37-AC-CS hydrogel exhibited remarkable antimicrobial and antitoxin efficacy as compared to the controls. The wound healing efficacy was evident in increased wound closure rate and decrease in bacterial bioburden, and favourable changes in wound healing biomarkers namely the myeloperoxidase, interleukin-6 and tumour necrosis factor α. The elevation of hydroxyproline levels in the LPS-treated wound model indicates there was collagen synthesis. In conclusion, the results presented in this study have significantly enhanced our comprehension of the LL37-AC-CS hydrogel's potential in wound healing. Specifically, the research highlights its effectiveness in eliminating endotoxins and preventing bacterial growth.

摘要

伤口愈合是一个复杂的过程,对康复至关重要。由病原体导致的伤口愈合延迟已带来重大临床影响,全球数百万患者受其影响。铜绿假单胞菌引起的伤口感染极具挑战性,因为该菌对多种抗菌药物具有耐药性。这种革兰氏阴性菌会分泌内毒素脂多糖(LPS),它会阻碍伤口愈合,并可能导致严重并发症,包括危及生命的败血症。此前,我们实验室已成功研发出一种含有合成抗菌肽的新型水凝胶,作为传统抗生素的替代疗法。这种水凝胶包含嵌入活性炭 - 壳聚糖水凝胶(LL37 - AC - CS)中的LL37微球。LL37 - AC - CS已显示出理想的物理化学性质以及体外有前景的抗菌和抗毒素活性。本研究有两个主要目标。第一个目标是评估LL37 - AC - CS水凝胶在感染铜绿假单胞菌的大鼠全层伤口中的体内抗菌效果。第二个目标是研究其对用大肠杆菌内毒素LPS处理的大鼠伤口模型的抗毒素效果。从宏观外观、伤口收缩率、组织学和伤口组织生化标志物等方面评估伤口愈合效果。结果显示,与对照组相比,LL37 - AC - CS水凝胶表现出显著的抗菌和抗毒素效果。伤口愈合效果明显体现在伤口闭合率增加、细菌生物负荷降低,以及伤口愈合生物标志物即髓过氧化物酶、白细胞介素 - 6和肿瘤坏死因子α出现有利变化。LPS处理的伤口模型中羟脯氨酸水平升高表明有胶原蛋白合成。总之,本研究结果显著增强了我们对LL37 - AC - CS水凝胶在伤口愈合方面潜力的理解。具体而言,该研究突出了其在消除内毒素和防止细菌生长方面的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验